Health Catalyst (HCAT) Stock Overview
Provides data and analytics technology and services to healthcare organizations in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
HCAT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Health Catalyst, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.01 |
| 52 Week High | US$5.06 |
| 52 Week Low | US$0.97 |
| Beta | 1.82 |
| 1 Month Change | -44.51% |
| 3 Month Change | -59.11% |
| 1 Year Change | -73.63% |
| 3 Year Change | -92.12% |
| 5 Year Change | -98.05% |
| Change since IPO | -97.42% |
Recent News & Updates
Recent updates
Improved Revenues Required Before Health Catalyst, Inc. (NASDAQ:HCAT) Shares Find Their Feet
Feb 13
Improved Revenues Required Before Health Catalyst, Inc. (NASDAQ:HCAT) Shares Find Their Feet
Oct 28Health Catalyst, Inc. (NASDAQ:HCAT) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 13Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Aug 04Health Catalyst: Ignite Platform Is A Growth Catalyst
Jun 10Health Catalyst, Inc. (NASDAQ:HCAT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 09
Ignite Transition And Recent Acquisitions Will Expand Global Footprint
Cross-selling through the Ignite platform is projected to boost client additions and accelerate revenue growth.Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook
Mar 25Take Care Before Jumping Onto Health Catalyst, Inc. (NASDAQ:HCAT) Even Though It's 27% Cheaper
Mar 08Health Catalyst (NASDAQ:HCAT) Has Debt But No Earnings; Should You Worry?
Feb 27It's A Story Of Risk Vs Reward With Health Catalyst, Inc. (NASDAQ:HCAT)
Jan 15Health Catalyst: Improved Demand Environment Reinforces My Buy Rating
Dec 18Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17Health Catalyst: Stellar Earnings Growth Projected
Jun 26Shareholder Returns
| HCAT | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -13.7% | -7.2% | 3.4% |
| 1Y | -73.6% | -35.4% | 29.7% |
Return vs Industry: HCAT underperformed the US Healthcare Services industry which returned -34.8% over the past year.
Return vs Market: HCAT underperformed the US Market which returned 25.7% over the past year.
Price Volatility
| HCAT volatility | |
|---|---|
| HCAT Average Weekly Movement | 12.1% |
| Healthcare Services Industry Average Movement | 10.4% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: HCAT's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: HCAT's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,200 | Ben Albert | www.healthcatalyst.com |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics.
Health Catalyst, Inc. Fundamentals Summary
| HCAT fundamental statistics | |
|---|---|
| Market cap | US$75.79m |
| Earnings (TTM) | -US$177.97m |
| Revenue (TTM) | US$311.14m |
Is HCAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HCAT income statement (TTM) | |
|---|---|
| Revenue | US$311.14m |
| Cost of Revenue | US$156.50m |
| Gross Profit | US$154.63m |
| Other Expenses | US$332.61m |
| Earnings | -US$177.97m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.42 |
| Gross Margin | 49.70% |
| Net Profit Margin | -57.20% |
| Debt/Equity Ratio | 62.4% |
How did HCAT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/09 17:32 |
| End of Day Share Price | 2026/04/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Health Catalyst, Inc. is covered by 21 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhilin Long | Berenberg |
| David Larsen | BTIG |
| Richard Close | Canaccord Genuity |